Abstract
The current study delineates the development of gelatin-amylopectin-based phase-separated hydrogels for drug delivery applications. Gelatin and amylopectin were used as the representative protein and polysaccharide phases, respectively. The hydrogels were prepared by adding different proportions of amylopectin to gelatin solutions and subsequently cross-linking the mixture using glutaraldehyde. Microscopic analysis showed formation of phase-separated hydrogels. Secondary structure of gelatin was conserved within the hydrogels. The presence of amylopectin drastically reduced the rate of water absorption by the hydrogels. Viscoelastic analysis using stress relaxation study suggested an increase in the viscous component of the hydrogels with the increase in the amylopectin content. After incorporating amylopectin within the gelatin hydrogel, even though the bulk resistance remained unaltered, there was a corresponding variation in the capacitive elements of the equivalent electrical models. The release of the drug from the hydrogels was diffusion mediated. Suitable mathematical models were used for the analysis of the swelling (Peleg's model), viscoelastic (Weichert model), electrical (RQQ model) and drug release (Korsmeyer-Peppas and Peppas-Sahlin models) properties. The drug retained its antimicrobial activity within the hydrogels. An analysis of the results suggested that the developed hydrogels may be explored as matrices for controlled drug delivery applications.